| P50 | author | Stephan Bour | Q55464748 |
| P2093 | author name string | Klaus Strebel | |
| | Paul Spearman | |
| | Rita M Smith | |
| | Vasundhara Varthakavi | |
| P2860 | cites work | Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding | Q24291784 |
| | Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses | Q24561846 |
| | Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments | Q24646897 |
| | The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation | Q24676509 |
| | Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 |
| | Cell type-dependence for Vpu function | Q28241247 |
| | A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif | Q28276184 |
| | Evidence for a newly discovered cellular anti-HIV-1 phenotype | Q28290967 |
| | A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5 | Q28344177 |
| | SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo | Q28362194 |
| | Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 |
| | Identification of the regions of Fv1 necessary for murine leukemia virus restriction. | Q33851839 |
| | Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts | Q34466295 |
| | Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes | Q35852056 |
| | The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. | Q35854362 |
| | The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? | Q35854386 |
| | The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses | Q35866801 |
| | The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. | Q35873115 |
| | Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs | Q36793376 |
| | The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release | Q36800610 |
| | Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein | Q36830393 |
| | Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. | Q38316167 |
| | Restriction of multiple divergent retroviruses by Lv1 and Ref1 | Q39056684 |
| | Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons | Q40066675 |
| | Generation of high-titer pseudotyped retroviral vectors with very broad host range | Q40571115 |
| | Function of human immunodeficiency virus type 1 Vpu protein in various cell types. | Q41277102 |
| | Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs | Q41686213 |
| | The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. | Q43521980 |
| | Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release. | Q44426365 |
| | p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents | Q45761377 |
| | Gag-Pol region determines the tropism of SIVagm for human cells | Q46612375 |
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 15154-15159 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production | |
| P478 | volume | 100 | |